ENDRA Life Sciences Inc. - FORM S-1/A - EX-23.1 - CONSENT OF RBSM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - December 6, 2016

Attached files

file filename
EX-3.3 - ARTICLES OF INCORPORATION / BYLAWS - ENDRA Life Sciences Inc.end_ex33.htm
EX-10.6 - MATERIAL CONTRACTS - ENDRA Life Sciences Inc.end_ex106.htm
EX-10.5 - MATERIAL CONTRACTS - ENDRA Life Sciences Inc.end_ex105.htm
EX-10.4 - ENDRA LIFE SCIENCES INC 2016 OMNIBUS INCENTIVE PLAN TO BE IN EFFECT UPON COMPLET - ENDRA Life Sciences Inc.end_ex104.htm
EX-5.1 - OPINION OF K&L GATES LLP - ENDRA Life Sciences Inc.end_ex51.htm
EX-4.3 - FORM OF UNDERWRITERS WARRANT - ENDRA Life Sciences Inc.end_ex43.htm
EX-4.2 - FORM OF WARRANT AGREEMENT AND WARRANT - ENDRA Life Sciences Inc.end_ex42.htm
EX-3.6 - ARTICLES OF INCORPORATION / BYLAWS - ENDRA Life Sciences Inc.end_ex36.htm
EX-3.4 - ARTICLES OF INCORPORATION / BYLAWS - ENDRA Life Sciences Inc.end_ex34.htm
EX-1.1 - UNDERWRITING AGREEMENT - ENDRA Life Sciences Inc.end_ex11.htm
S-1/A - AMENDMENT NO.1 - ENDRA Life Sciences Inc.end_drs.htm
 
Exhibit 23.1
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the reference to our firm under the caption “Experts” and the use of our report dated July 15, 2016 (except for the effect of the restatement discussed in Note 3 to the financial statements, for which the date is August 4, 2016), which includes an explanatory paragraph regarding the substantial doubt about the Company’s ability to continue as a going concern, on the financial statements of Endra Life Sciences Inc. which appears in this Registration Statement on Form S-1 Amendment No. 1.
/s/ RBSM LLP
Henderson, NV
December 6, 2016
 
 
 

ENDRA Life Sciences Inc. Reports